Skip to main content
. 2019 Nov 27;9:17728. doi: 10.1038/s41598-019-53982-w

Figure 6.

Figure 6

Cromolyn treatment does not alter microgliosis in the spinal cord of TgSOD1 mice. (a) Microglia of the lumbar spinal cord were visualized using the Iba1-specific antibody and DAB staining. (b) Quantifications of the percentage of Iba1+ cell area revealed no difference in the percentage of Iba1+ cell area in TgSOD1-Cromolyn mice compared to TgSOD1-Vehicle. There was a significant increase in the percentage of Iba1+ cell area in the spinal cord of both TgSOD1-Vehicle and TgSOD1-Cromolyn compared to both Wt groups as demonstrated by two-way ANOVA and Tukey’s post-hoc analysis. Wt-Vehicle (n = 19; light grey), Wt-Cromolyn (n = 17; dark grey), TgSOD1-Vehicle (n = 19; black), and TgSOD1-Cromolyn (n = 17; red). *Denotes differences between TgSOD1-Vehicle and Tg-SOD1-Cromolyn; ^denotes differences between TgSOD1-Vehicle and Wt-Vehicle; #denotes differences between TgSOD1-Vehicle and Wt-Cromolyn; @denotes differences between TgSOD1-Cromolyn and Wt-Vehicle; %denotes differences between TgSOD1-Cromolyn and Wt-Cromolyn. ****p < 0.0001, the same statistical significance is associated with each symbol. Data are presented as median and interquartile ranges. Scale bar = 500 μm.